PRF Technologies

PRF Technologies AAQS

The The AAQS of PRF Technologies (PRFX) as of Oct 18, 2026 is 1. In the previous year, The AAQS was 1.00 — a change of 0.00% (lower).

AAQS

1

YoY

0.00%

Last updated:

PRF Technologies has a current AAQS of 1.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock PRF Technologies in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.

The PRF Technologies AAQS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

AAQS
Date
AAQS
Jan 1, 2018
1.00 USD
Jan 1, 2019
1.00 USD
Jan 1, 2020
1.00 USD
Jan 1, 2021
1.00 USD
Jan 1, 2022
1.00 USD
Jan 1, 2023
1.00 USD
Jan 1, 2024
1.00 USD
Jan 1, 2025
1.00 USD
The PRF Technologies AAQS history
YEARAAQSYoY
10.00%
10.00%
10.00%
10.00%
10.00%
10.00%
10.00%
10.00%
1—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PRF Technologies Stock analysis

What does PRF Technologies do? PRF Technologies Ltd, listed under the ticker PRFX with ISIN IL0011651580, is a pharmaceutical company based in Tel Aviv-Yafo, Israel. The company operates within the Health Care sector and has a workforce of six employees. PRF Technologies Ltd. went public on September 1, 2020. Its website is https://painreform.com/. The company focuses on reformulating established therapeutics, particularly in the area of pain management. PRF Technologies Ltd. develops reformulated pain therapeutics designed to prolong efficacy, enhance therapeutic outcomes, minimize adverse effects, and improve patient convenience. The company's technology aims to facilitate a faster return of motor function for patients. The company's activities are centered on leveraging existing pharmaceuticals to create more effective and user-friendly treatments without introducing new active ingredients. PRF Technologies Ltd. is engaged in the development of innovative approaches to pain management, emphasizing the optimization of current therapeutic options. PRF Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PRF Technologies stock

The AAQS of PRF Technologies is 1 in 2025.

On Eulerpool you can find the complete historical development of The AAQS PRF Technologies since 2006 – with annual values, charts, and detailed analysis.

The AAQS is a key figure developed by AlleAktien.

The AAQS is a key figure developed by AlleAktien.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — PRF Technologies

All Key Metrics — PRF Technologies